Manning & Napier Group's PFE Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 49,073 shares of Pfizer Inc. (PFE) worth $1.23 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2023, adding 287,261 shares. Largest reduction occurred in Q2 2024, reducing 820,365 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +49,073 | New Buy | 49,073 | $24.99 |
| Q2 2024 | -820,365 | Sold Out | 0 | $0.00 |
| Q1 2024 | -53,889 | Reduce 6.16% | 820,365 | $27.75 |
| Q4 2023 | -152,276 | Reduce 14.83% | 874,254 | $28.79 |
| Q3 2023 | -30,419 | Reduce 2.88% | 1.03 M | $33.17 |
| Q2 2023 | +287,261 | Add 37.32% | 1.06 M | $36.68 |
| Q1 2023 | -1,811 | Reduce 0.23% | 769,688 | $40.80 |
| Q4 2022 | -5,768 | Reduce 0.74% | 771,499 | $51.24 |
| Q3 2022 | -11,859 | Reduce 1.50% | 777,267 | $43.76 |
| Q2 2022 | +789,126 | New Buy | 789,126 | $52.43 |
| Q2 2021 | -1.46 M | Sold Out | 1.46 M | $36.23 |
| Q1 2021 | +30,588 | Add 2.15% | 1.46 M | $36.23 |
| Q4 2020 | -77,106 | Reduce 5.13% | 1.42 M | $36.81 |
| Q3 2020 | +9,717 | Add 0.65% | 1.5 M | $36.70 |
| Q2 2020 | +25,054 | Add 1.71% | 1.49 M | $32.70 |
| Q1 2020 | +37,009 | Add 2.59% | 1.47 M | $32.64 |
| Q4 2019 | +103,183 | Add 7.78% | 1.43 M | $39.18 |
| Q3 2019 | +46,762 | Add 3.65% | 1.33 M | $35.93 |
| Q2 2019 | +73,727 | Add 6.11% | 1.28 M | $43.32 |
| Q1 2019 | +252,583 | Add 26.48% | 1.21 M | $42.47 |
| Q4 2018 | +61,285 | Add 6.87% | 953,701 | $43.65 |
| Q3 2018 | +52,240 | Add 6.22% | 892,416 | $44.07 |
| Q2 2018 | -135,402 | Reduce 13.88% | 840,176 | $36.28 |
| Q1 2018 | +199,583 | Add 25.72% | 975,578 | $35.49 |
| Q4 2017 | +775,996 | Add 0.00% | 775,995 | $36.22 |
| Q3 2017 | +1,979 | Add 0.24% | 838,007 | $35.70 |
| Q2 2017 | +116,595 | Add 16.21% | 836,028 | $33.59 |
| Q1 2017 | +35,433 | Add 5.18% | 719,433 | $34.21 |
| Q4 2016 | +38,974 | Add 6.04% | 684,000 | $32.48 |
| Q3 2016 | -6,014 | Reduce 0.92% | 645,026 | $33.87 |
| Q2 2016 | -75,220 | Reduce 10.36% | 651,040 | $35.21 |
| Q1 2016 | -8,771 | Reduce 1.19% | 726,260 | $29.64 |
| Q4 2015 | -22,672 | Reduce 2.99% | 735,031 | $32.28 |
| Q3 2015 | -36,019 | Reduce 4.54% | 757,703 | $31.41 |
| Q2 2015 | -82,597 | Reduce 9.43% | 793,722 | $33.53 |
| Q1 2015 | -7,250 | Reduce 0.82% | 876,319 | $34.79 |
| Q4 2014 | +41,103 | Add 4.88% | 883,569 | $31.15 |
| Q3 2014 | -39,851 | Reduce 4.52% | 842,466 | $29.57 |
| Q2 2014 | -16,864 | Reduce 1.88% | 882,317 | $29.68 |
| Q1 2014 | -128,153 | Reduce 12.47% | 899,181 | $32.12 |
| Q4 2013 | -91,676 | Reduce 8.19% | 1.03 M | $30.63 |
| Q3 2013 | +1,673 | Add 0.15% | 1.12 M | $28.72 |
| Q2 2013 | +1.12 M | Add 0.00% | 1.12 M | $28.01 |
Manning & Napier Group's Pfizer Investment FAQs
Manning & Napier Group first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 1,117,337 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Pfizer Inc. (PFE) for 46 quarters since Q2 2013.
Manning & Napier Group's largest addition to Pfizer Inc. (PFE) was in Q2 2013, adding 1,117,337 shares worth $31.3 M.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 49,073 shares of Pfizer Inc. (PFE), valued at approximately $1.23 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.02% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Pfizer Inc. (PFE) was 1,501,736 shares, as reported at the end of Q3 2020.